ZYMEWORKS INC. Employee Count
The employee counts ZYMEWORKS INC. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 264; Filing 2026-03-02; Lease expense per employee $21,257.58.
- 2024-12-31: Employees (as filed) 286; Filing 2025-03-05; Lease expense per employee $19,052.45.
- 2023-12-31: Employees (as filed) 277; Filing 2024-03-06; Lease expense per employee $32,234.66.
- 2022-12-31: Employees (as filed) 294; Filing 2023-03-07; Lease expense per employee $26,513.61.
- Available history
- 2022-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 264 full-time | 2026-03-02 | $21,257.58 total lease cost |
| 2024-12-31 | 286 full-time | 2025-03-05 | $19,052.45 total lease cost |
| 2023-12-31 | 277 full-time | 2024-03-06 | $32,234.66 total lease cost |
| 2022-12-31 | 294 full-time | 2023-03-07 | $26,513.61 total lease cost |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |